3547 results for «203»
3547 results
Rapid-Fire - Tricuspid TEER
25 Nov 2024 – From PCR London Valves 2024
Discover a rapid-fire session showcasing selected PCR London Valves 2024 clinical cases focused on Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER). Explore a range of complications and innovative solutions, such as cardiogenic shock, single leaflet device attachment, and increased transvalvular gradients. Gain valuable insights into the challenges and...
Mind the gap! - What's missing in the field of transcatheter valve interventions
25 Nov 2024 – From PCR London Valves 2024
Explore the key requirements for broadly adopting Transcatheter Mitral Valve Repair (TMVR), examine the challenges of Left Ventricular Outflow Tract Obstruction in Mitral Valve Replacement (MVR), and identify the additional tools needed for effective mitral valve repair. This session will provide a comprehensive assessment of the...
BIOMAG-I clinical trial reaches primary endpoint at six month for unique next generation resorbable magnesium scaffold
23 Sep 2022
Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial
31 Aug 2021
Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
